Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression

Figure 4

The expression levels of TRAIL and DcR2 are markedly reduced in oral premalignancy compared to normal oral mucosa. Graphic depiction of the mean expression levels of TRAIL and TRAIL-R in patient matched normal oral mucosa (NOM), oral premalignancies (OPM: leukoplakias with dysplasia). Mean expression levels of DR4, DR5 and DcR1 did not differ significantly between normal oral mucosa (NOM) and oral premalignancies (OPM).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us